skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors

Abstract

Macrophage migration inhibitory factor (MIF) is a master regulator of proinflammatory cytokines and plays pathological roles when not properly regulated in rheumatoid arthritis, lupus, atherosclerosis, asthma and cancer. Unlike canonical cytokines, MIF has vestigial keto-enol tautomerase activity. Most of the current MIF inhibitors were screened for the inhibition of this enzymatic activity. However, only some of the enzymatic inhibitors inhibit receptor-mediated biological functions of MIF, such as cell recruitment, through an unknown molecular mechanism. The goal of this study was to understand the molecular basis underlying the pharmacological inhibition of biological functions of MIF. Here, we demonstrate how the structural changes caused upon inhibitor binding translate into the alteration of MIF-induced downstream signalling. Macrophage migration inhibitory factor activates phosphoinositide 3-kinases (PI3Ks) that play a pivotal role in immune cell recruitment in health and disease. There are several different PI3K isoforms, but little is known about how they respond to MIF. We demonstrate that MIF up-regulates the expression of Class IB PI3Ks in leucocytes. We also demonstrate that MIF tautomerase active site inhibitors down-regulate the expression of Class IB PI3Ks as well as leucocyte recruitment in vitro and in vivo. Finally, based on our MIF:inhibitor complex crystal structures, we hypothesize thatmore » the reduction in Class IB PI3K expression occurs because of the displacement of Pro1 towards the second loop of MIF upon inhibitor binding, which results in increased flexibility of the loop 2 and sub-optimal MIF binding to its receptors. These results will provide molecular insights for fine-tuning the biological functions of MIF.« less

Authors:
 [1];  [2];  [3];  [1];  [1]
  1. Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis MO USA
  2. Department of Pharmacology, Yale University School of Medicine, New Haven CT USA
  3. Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, Aachen Germany
Publication Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
OSTI Identifier:
1409606
Report Number(s):
BNL-114658-2017-JA¿¿¿
Journal ID: ISSN 1582-1838
DOE Contract Number:  
SC0012704
Resource Type:
Journal Article
Journal Name:
Journal of Cellular and Molecular Medicine
Additional Journal Information:
Journal Volume: 21; Journal Issue: 1; Journal ID: ISSN 1582-1838
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, and Cho, Thomas Yoonsang. Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors. United States: N. p., 2016. Web. doi:10.1111/jcmm.12949.
Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, & Cho, Thomas Yoonsang. Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors. United States. doi:10.1111/jcmm.12949.
Singh, Abhay Kumar, Pantouris, Georgios, Borosch, Sebastian, Rojanasthien, Siripong, and Cho, Thomas Yoonsang. Tue . "Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors". United States. doi:10.1111/jcmm.12949.
@article{osti_1409606,
title = {Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors},
author = {Singh, Abhay Kumar and Pantouris, Georgios and Borosch, Sebastian and Rojanasthien, Siripong and Cho, Thomas Yoonsang},
abstractNote = {Macrophage migration inhibitory factor (MIF) is a master regulator of proinflammatory cytokines and plays pathological roles when not properly regulated in rheumatoid arthritis, lupus, atherosclerosis, asthma and cancer. Unlike canonical cytokines, MIF has vestigial keto-enol tautomerase activity. Most of the current MIF inhibitors were screened for the inhibition of this enzymatic activity. However, only some of the enzymatic inhibitors inhibit receptor-mediated biological functions of MIF, such as cell recruitment, through an unknown molecular mechanism. The goal of this study was to understand the molecular basis underlying the pharmacological inhibition of biological functions of MIF. Here, we demonstrate how the structural changes caused upon inhibitor binding translate into the alteration of MIF-induced downstream signalling. Macrophage migration inhibitory factor activates phosphoinositide 3-kinases (PI3Ks) that play a pivotal role in immune cell recruitment in health and disease. There are several different PI3K isoforms, but little is known about how they respond to MIF. We demonstrate that MIF up-regulates the expression of Class IB PI3Ks in leucocytes. We also demonstrate that MIF tautomerase active site inhibitors down-regulate the expression of Class IB PI3Ks as well as leucocyte recruitment in vitro and in vivo. Finally, based on our MIF:inhibitor complex crystal structures, we hypothesize that the reduction in Class IB PI3K expression occurs because of the displacement of Pro1 towards the second loop of MIF upon inhibitor binding, which results in increased flexibility of the loop 2 and sub-optimal MIF binding to its receptors. These results will provide molecular insights for fine-tuning the biological functions of MIF.},
doi = {10.1111/jcmm.12949},
journal = {Journal of Cellular and Molecular Medicine},
issn = {1582-1838},
number = 1,
volume = 21,
place = {United States},
year = {2016},
month = {9}
}

Works referenced in this record:

Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997

  • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
  • DOI: 10.1107/S0907444996012255

MIF Signal Transduction Initiated by Binding to CD74
journal, June 2003

  • Leng, Lin; Metz, Christine N.; Fang, Yan
  • The Journal of Experimental Medicine, Vol. 197, Issue 11
  • DOI: 10.1084/jem.20030286

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
journal, April 2007

  • Bernhagen, Jürgen; Krohn, Regina; Lue, Hongqi
  • Nature Medicine, Vol. 13, Issue 5
  • DOI: 10.1038/nm1567

Structural Interactions Dictate the Kinetics of Macrophage Migration Inhibitory Factor Inhibition by Different Cancer-Preventive Isothiocyanates
journal, September 2012

  • Crichlow, Gregg V.; Fan, Chengpeng; Keeler, Camille
  • Biochemistry, Vol. 51, Issue 38
  • DOI: 10.1021/bi3005494

An Analysis of MIF Structural Features that Control Functional Activation of CD74
journal, September 2015


The CCP4 suite programs for protein crystallography
journal, September 1994


Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement
journal, March 2003


Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206